1294 related articles for article (PubMed ID: 9691088)
1. IL-1 produced and released endogenously within human islets inhibits beta cell function.
Arnush M; Heitmeier MR; Scarim AL; Marino MH; Manning PT; Corbett JA
J Clin Invest; 1998 Aug; 102(3):516-26. PubMed ID: 9691088
[TBL] [Abstract][Full Text] [Related]
2. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes.
Arnush M; Scarim AL; Heitmeier MR; Kelly CB; Corbett JA
J Immunol; 1998 Mar; 160(6):2684-91. PubMed ID: 9510167
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1.
Heitmeier MR; Scarim AL; Corbett JA
J Biol Chem; 1997 May; 272(21):13697-704. PubMed ID: 9153221
[TBL] [Abstract][Full Text] [Related]
4. Double-stranded RNA inhibits beta-cell function and induces islet damage by stimulating beta-cell production of nitric oxide.
Heitmeier MR; Scarim AL; Corbett JA
J Biol Chem; 1999 Apr; 274(18):12531-6. PubMed ID: 10212230
[TBL] [Abstract][Full Text] [Related]
5. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase.
Corbett JA; McDaniel ML
J Exp Med; 1995 Feb; 181(2):559-68. PubMed ID: 7530759
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production.
Thomas HE; Darwiche R; Corbett JA; Kay TW
Diabetes; 2002 Feb; 51(2):311-6. PubMed ID: 11812737
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.
Corbett JA; Sweetland MA; Wang JL; Lancaster JR; McDaniel ML
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1731-5. PubMed ID: 8383325
[TBL] [Abstract][Full Text] [Related]
8. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
Darville MI; Eizirik DL
Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets.
Corbett JA; Kwon G; Marino MH; Rodi CP; Sullivan PM; Turk J; McDaniel ML
Am J Physiol; 1996 Jun; 270(6 Pt 1):C1581-7. PubMed ID: 8764139
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production.
Flodström M; Eizirik DL
Endocrinology; 1997 Jul; 138(7):2747-53. PubMed ID: 9202213
[TBL] [Abstract][Full Text] [Related]
11. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.
Maggi LB; Sadeghi H; Weigand C; Scarim AL; Heitmeier MR; Corbett JA
Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955
[TBL] [Abstract][Full Text] [Related]
13. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
Eizirik DL; Sandler S; Welsh N; Cetkovic-Cvrlje M; Nieman A; Geller DA; Pipeleers DG; Bendtzen K; Hellerström C
J Clin Invest; 1994 May; 93(5):1968-74. PubMed ID: 7514190
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression in pancreatic islets.
Baker MS; Chen X; Rotramel AR; Nelson JJ; Kaufman DB
Surgery; 2003 Aug; 134(2):134-41. PubMed ID: 12947309
[TBL] [Abstract][Full Text] [Related]
15. Prolonged STAT1 activation is associated with interferon-gamma priming for interleukin-1-induced inducible nitric-oxide synthase expression by islets of Langerhans.
Heitmeier MR; Scarim AL; Corbett JA
J Biol Chem; 1999 Oct; 274(41):29266-73. PubMed ID: 10506184
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement.
Dunger A; Cunningham JM; Delaney CA; Lowe JE; Green MH; Bone AJ; Green IC
Diabetes; 1996 Feb; 45(2):183-9. PubMed ID: 8549863
[TBL] [Abstract][Full Text] [Related]
18. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.
Salkowski CA; Detore G; McNally R; van Rooijen N; Vogel SN
J Immunol; 1997 Jan; 158(2):905-12. PubMed ID: 8993010
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
Andersson AK; Flodström M; Sandler S
Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]